New peripheral venous and arterial crossing tool paves a path to Europe SALT LAKE CITY, Feb. 06, 2020 (GLOBE NEWSWIRE) — XableCath, Inc., announced its XableCath™ Crossing Catheters have received CE Mark for peripheral use. Its crossing devices will be […]
Tag: XableCath
XableCath Crossing Catheters FDA Cleared
SALT LAKE CITY, Jan. 30, 2019 (GLOBE NEWSWIRE) — XableCath, Inc., announced that its XableCath™ blunt and abrasion tip catheters, were cleared by the FDA as Peripheral Crossing Catheters. The catheters have been safely and successfully used to cross challenging […]
XableCath Catheters Demonstrate Ability to Cross Chronic Venous Occlusions
SALT LAKE CITY–(BUSINESS WIRE)–XableCath, a commercial-stage medical device company, announced today that it has demonstrated initial safety and efficacy of its unique catheters for use with chronic venous occlusions, commonly characterized by recalcitrant lesions that have historically proven difficult to […]
XableCath Receives Second FDA Clearance for Its Peripheral Arterial Catheters
SALT LAKE CITY–(BUSINESS WIRE)–XableCath, Inc., innovators of products designed to aid in the treatment of peripheral artery disease (PAD), announced that its second catheter, XableCath™ abrasion tip support catheter, was cleared by the FDA. The XableCath blunt tip catheter received […]
XableCath Granted United States Patent for its Peripheral Arterial Catheters
SALT LAKE CITY–(BUSINESS WIRE)– XableCath, Inc., innovators of products designed to aid in the treatment of peripheral artery disease (PAD), announced that it has been granted a second U.S. Patent, No. 9,826,995, covering its XableCath™ catheter. The patent specifically describes […]
XableCath Scores FDA Clearance for Broadly Effective Catheter
SALT LAKE CITY–(BUSINESS WIRE)– XableCath, a clinical stage medical device company, announced its XableCath blunt tip support catheter has received clearance from the FDA. The blunt tip catheter facilitates true lumen passage of lesions, both above and below the knee, in the […]